- Presentations
- 3
- Markets
- 1
Neulasta is a brand of Pegfilgrastim marketed by Amgen, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pegfilgrastim
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- 4 mg/0.4 mL injection, 6 mg/0.6 mL injection, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Neulasta 4 mg/0.4 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Neulasta 6 mg/0.6 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Neulasta kit Cold chain | Amgen | US FDA | Available on request |
Equivalent brands
Other brands of Pegfilgrastim.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Neulasta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.